Open Access and Free to Publish in Asian Journal of Health Sciences

Research articles Open Access Logo

Using Traditional Medicinal Plants from Arid and Desert Rangelands as a Potential Treatment for Covid-19 in Southern Tunisia

Mouldi Gamoun 1, *
  1. International Center for Agricultural Research in the Dry Areas (ICARDA), 2049 Ariana, Tunisia
Correspondence to: Mouldi Gamoun, International Center for Agricultural Research in the Dry Areas (ICARDA), 2049 Ariana, Tunisia. Email: M.Gamoun@cgiar.org.
Volume & Issue: Vol. 7 No. 2 (2021) | Page No.: ID21 | DOI: 10.15419/ajhs.v7i2.491
Published: 2021-10-01

Online metrics


Statistics from the website

  • HTML Views: 128426
  • PDF Views: 791
  • XML Views: 12

Statistics from Dimensions

Copyright The Author(s) 2017. This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. 

Abstract

Rangelands provide good services, including forage for livestock, aromatic and medicinal plants, wildlife habitat, fuel wood, and the watershed. In the arid and desert rangelands of Tunisia, several medicinal plants are used locally in traditional medicine. Many of them have been scientifically investigated and validated. This study aimed to document the different plants used recently to treat and prevent Covid-19 by the rural communities in southern Tunisia. One hundred persons that were ensured to be cured after their infection by Covid-19 were asked to indicate what plants were used to prevent or treat the pandemic disease. It is noteworthy that the selected respondents did not use any other medication than medicinal plants due to the high price of medicament. Additionally, they had not received any Covid-19 vaccinations to date. Five species were harvested from the range lands to be used by the rural population in south Tunisia to treat and prevent Covid- 19. The plants included Rosmarinus officinalis, Thymbra capitata, Peganum harmala, Artemisia herbaalba and Astragalus armatus. These species are medicinally essential when it comes to treating several human diseases. Still, there are no new scientific findings on whether these conclusions are valid. These results can still be the subject of future scientific research.

Introduction

Native range lands are an important source of rare and environmentally, economically, nutritionally, and medically valued plants around the globe. In recent decades, increased attention has been paid to the potential of wild plants in terms of medicinal uses. In many regions of the world, most medicinal plants grow in natural range lands rather than being planted1. In China, for example, it is estimated that 80% of medicinal plants are provided by the natural resources2, 3. In addition, it is estimated that 80% of the world population uses herbal medicine as part of its primary health care, with about 12 % being from South Asia4. Given the importance of plants in medicine, the Sri Lankan Government established the Ministry of Indigenous Medicine in 1980 due to the high demand for the drugs based on plants5.

The arid environment is also one of diversity in terms of medicinal herbs and it is home to a large number of unique species6. Despite being under threat from various biotic and abiotic stresses, many arid range lands still produce medicinal plants that are valued in both traditional and modern medicine. Their harvesting greatly contributes to the annual livelihood income of many populations7, 8, 9. The excessive and unsustainable collection of medicinal plants on a large scale from the range lands contributes to rangeland degradation and the extinction of some plant species10.

Tunisia’s rangelands occupy about 5.5 million ha, of which 87% of them are arid11. These lands form the largest part of the Tataouine governorate surface, making up about 27% of the total rangeland in Tunisia12. Despite these harsh environments, arid rangelands are blessed with a wide diversity of medicinal plants due to their diverse ecological habitats13, 14, 15. An ethnobotanical survey conducted of a local community in Tataouine reported that 70 plant species are used for therapeutic purposes16. Through the floristic surveys conducted by Gamoun and Louhaichi12, a total of 279 species were recorded in the rangelands of Tataouine, and 35 of them were found to be greatly used in both traditional and modern medicine.

Given the spread of diseases, medicinal plants are gaining attention in the context of traditional use. Recently, more than 199 million infections with at least 4 million Covid-19 associated deaths were reported by July 202117.

Tunisia is among the countries most severely affected by the ongoing pandemic, with more than 560 thousand infections and at least 18 thousand deaths reported by July 202117. In light of the Covid-19 pandemic, the fragile health care system, and the lack of infrastructure, the use of medicinal plants has acquired a renewed interest by the rural population of Tunisia. The present study has therefore attempted to reveal some of the medicinal plants used in the south of Tunisia to prevent or treat Covid-19 infection.

Methodology

Tataouine is located in the south of Tunisia, totaling 150 thousand inhabitants. It recorded close to 10,500 coronavirus cases and 410 deaths by the end of July 202118. Due to this record of infection, the slow pace of vaccination in Tunisia, and the mistrust in the available Covid-19 vaccines held by some people, the community has become increasingly disappointed. This has led them to using native plants which may help them to address the current pandemic. In July 2021, 100 persons that were cured of Covid-19 were asked to indicate what plants were used to prevent or treat the disease. It is noteworthy that the selected respondents did not use any medication other than the medicinal plants due to the high price of medication and that they had not received any Covid-19 vaccinations to date.

Results and Discussion

Botanical studies conducted in the arid and desert rangeland of Tataouine have identified a rich collection of over 270 plants from 58 families11, 12, where 65% of the family contributions are from Asteraceae, Poaceae, Fabaceae, Amaranthaceae, Brassicaceae, Boraginaceae, Caryophyllaceae, Lamiaceae, Apiaceae, and Cistaceae. The rangeland is botanically endowed with rich and diverse medicinal plants where 35 plant species belonging to 15 families are greatly used in both traditional and modern medicine. Lamiaceae and Apiaceae were found to occur in the highest proportion for medicinal use. The families with the highest number of species were Lamiaceae with 6 species, Apiaceae with 4, Amaryllidaceae Amaranthaceae, Asteraceae, Brassicaceae, Amaryllidaceae, Ephedraceae, Fabaceae, Nitrariaceae, Poaceae, Polygonaceae, Ephedraceae, Fabaceae, Nitrariaceae, Poaceae, Polygonaceae with 2 species each, and Apocynaceae, Capparaceae, Caryophyllaceae, Cucurbitaceae, Rhamnaceae, Thymelaeaceae, Zygophyllaceae with a single species each.

Five species were harvested from the rangelands and used by the local community to treat and prevent Covid-19 (Table 1). These included and

Table 1

Traditional medicinal plants used by local population in the south of Tunisia against Covid-19

Plant species

Common name

Part used

Indication

R. officinalis

Rosemary

Leaves

Boiling dried leaves of rosemary in water and drank when it cools.

T. capitata

Conehead thyme

Leaves

Boiling dried leaves of T. capitata in water and drank when it cools.

To treat coughs, fever, and bronchitis, leaf powder is mixed with honey and applied to the chest.

P. harmala

Wild rue

Stems, leaves and seeds

Wild rue smoke efficacy against Covid-19: putting leaves, seeds, stems, on hot coals, and breathe the smoke through the nose, and it will cause all rheum to go away.

Fumigate the home to prevent the spread of all kinds of infectious diseases.

A. herba-alba

White wormwood

Leaves

Putting the leaves of A. herba-alba on hot coals, and breathes the smoke through the nose, and it will cause all rheum to go away.

A. armatus

Milkvetch

Roots

Decoction of roots of A. armatus is orally taken to treat and prevent Covid-19, because it can stimulate the immune system and act against viruses like the ones that cause colds.

The most important species in terms of the number of users was , used by 47 people. In addition, was used by 25 people, followed by by 19 people, by 16 and by 12 people. Some of the respondents used pairs of species at a time. Of the 100 interviewed, 12 people used and , 5 people used and and 2 people used and .

Lis a perennial shrub native to the Mediterranean basin belonging to Lamiaceae family (Figure 1). It is more commonly known as rosemary and ‘‘” in classical Arabic. It has multiple uses including medicinal, aromatic, and ornamental19. as an essential oil has important inflammatory20, 21, 22, 23, antimutagenic24, 25, cytotoxic26, 27, 28, antiphlogistic24, 29, analgesic30, 31, 32, anti-obesity33 and hepatoprotective applications34, 35, as well as being used in the prevention and treatment of diabetic and cardiovascular diseases36. It is also well known for its biological active essential oils that are antioxidants37, 38, 39, anticancer40, 41, 28, antibacterial42, 43, and antifungal44, 45, 46. Moreover, is a pulmonary antiseptic, as well as stomachic, hypertensive, and antidiarrheal due to its diuretic and sudorific qualities15.

The leaves of were the most used plant part by the local people in the treatment of Covid-19. They boiled the dried rosemary leaves in water and drank it once it had cooled.

Figure 1

Rosmarinus officinalis L.

Figure 2

Thymbra capitata (L.) Cav.

Figure 3

Peganum harmala L.

Figure 4

Artemisia herba-alba Asso.

Figure 5

Astragalus armatus Willd.

(L.) Cavis a perennial herbaceous shrub native to the Mediterranean area, belonging to Lamiaceae family (Figure 2). It is commonly known as thyme and it is locally known as ‘‘”. In southern Tunisia, it is represented by scattered populations on sandy and often rocky soils. is known for the effectiveness of its essential oil as part of a local utilization for traditional medicinal purposes. It is widely used for folk medicinal purposes to treat arterial hypertension, ulcers, colic, digestive and respiratory system disorders, and diarrhea47, 48. Nowadays, the essential oil of is gaining interest due its potential biological properties49, 50. It is mainly known for being an antioxidant51, anti-inflammatory52, 53, antimicrobial54, 55, 56, cytotoxic57, 58, antimycotic59, 60, anticancer61, antiproliferative62, and antifungal63. These main biological activities were reported to be due to its richness of phenolic compounds in the extracted essential oils64, 65, 66.

The leaves of were found to be the plant part used the most by the local people in their treatment of Covid-19. They boiled the dried leaves of in water and drank the mixture when it cooled. Likewise, the leaf powder was also mixed with honey and applied to the chest to treat coughs, a fever, and bronchitis.

L. is a herbaceous perennial flowering plant that is widely distributed in Central Asia, North Africa, and the Middle East (Figure 3). It is commonly known as African rue, Syrian rue, and wild rue. This plant, known as in North Africa, belongs to the Nitrariaceae family. is a noxious invasive species. It is toxic to livestock when fresh but medicinally important67. The seeds are known to possess hypothermic properties68, 69 and it is effective in the treatment of dermatosis70. Furthermore, was shown to possess lactogogue, antihelmitic, antispasmodic, abortifient, antipyretic, emetic, emmenagogue, cardiovascular, neurologic, antimicrobial, gastrointestinal, anticancer, and antidiabetic activities71. It has also been found that has insecticidal and anti-tumor effects72, as well as being antileishmanial73, anti-spasmodic, anti-malaria72, vasorelaxant and anti-histaminic74. This is as well as promoting wound healing, antioxidant activity, immunomodulator properties, and leukemia healing75 with analgesic and anti-inflammatory properties. Finally, it also has antinociceptive76, hepatoprotective77, hypoglycemic, antitumor78, cytotoxic, antifungal, antibacterial and antiviral effects79.

To treat and prevent Covid-19, the local community takes any part of (leaves, seeds, stems, roots) and puts it on hot coals. They breathe in the smoke through the nose. This causes all of the rheum to go away.

Asso., is a perennial shrub belonging to the Asteraceae family. It is commonly known as white wormwood and it is locally known as ‘‘” (Figure 4). It is widespread in the arid and semi-arid steppes of North Africa, Southwestern Europe, and the Middle East. Since ancient times, has been extensively used in traditional medicine to treat hypertension, scorpion/snake bites, diabetes, colds, parasitic infections, intestinal disturbances, bronchitis, diarrhea, neuralgias, stomach pains, and hemorrhoids80, 81, 82, 83, 16. It is known for its antioxidant, anticancer, antimicrobial, anti-inflammatory, genotoxic, cytotoxic, antiacetylcholinesterase, and fungicidal activities84, 85, 86, 87, 88.

To treat and prevent Covid-19, the local community takes the leaves of and puts them on hot coals. They breathe in the smoke through the nose, and this causes all of the rheum to go away.

Willd. is a perennial spiny shrub native to Algeria, Libya, Morocco, and Tunisia. It is commonly known as thorny milkvetch and it is locally known as ‘‘” (Figure 5). has been used in traditional medicine as an effective treatment for leishmaniasis and helminthiasis89. It also relieves odentonecrosis16. Nowadays, pods of are receiving interest due to their potential antioxidant, anticholinesterase, antibacterial and phagocytic activities90. They are also a source of the bioactive galactomannan91. The genus Astragalus () is used to prevent colds and upper respiratory infections, to protect and support the immune system, to protect the liver, to decrease blood pressure, and to cure diabetes92, 93).

A water decoction of roots of is orally taken to treat and prevent Covid-19 because it can stimulate the immune system, helping it to fight against viruses like the ones that cause colds.

Fear used to grip the country. This seemed clear before the vaccine became available sufficiently. The intensification of the fourth wave of coronavirus has killed thousands of people. In this changing epidemiological situation, people have resorted to looking to plants to boost their immunity. Among the most used species, there are those that have been mentioned above such and Some native species have been traditionally valued for warding off winter flu, which shares some symptoms with the new coronavirus.

Recent studies have shown that and have been used by Tunisian and Moroccan Covid-19 patients due to their antiviral properties and the presence of various complex chemical substances that may play an important role in the inhibition of Covid-1994, 95. has a potential role, due to its natural antiviral compounds, in the development of plant-based drugs to use against coronavirus96, 97. evidence shows that a mixture of essential oils from three Cretan Aromatic Plants ( (L.) Cav., Mill. and L.) inhibits SASR-CoV-2 proliferation. This may be a valuable addition for the prevention and/or treatment of mild Covid-1998. The positive effects of against several viruses have been proven through experiments including SARS-CoV-2 and influenza virus, both of which have indications similar to Covid-19. This means that it is likely to be effective in the treatment of Covid-1999, 100. Asdadi . 101 and Attah . 102suggested that has possible potential against Covid-19 due to its antiviral activities. is used to treat several human diseases but there is no good scientific evidence to support its efficacy against Covid-19, although it may have some antiviral activity. Some Astragalus species, such as , have been used in traditional Chinese Medicine in the treatment of Covid-19103.

From these results, supported by other research findings and databases, we suggest that these species have potential against Covid-19 but more scientific research is required to validate their validity.

Conclusion

Today, the world faces an ongoing Covid-19 pandemic. This pandemic has become a significant challenge when it comes to human security. Tunisia, like every country in the world, is facing the Covid-19 pandemic and the many connected challenges that it has caused. Due to the increased price of the cost of medication and medical supplies and the projected increase in the incidence of Covid-19, the use of medicinal plants has grown rapidly among rural populations. The arid and desert range lands of Tunisia provide a habitat for several medicinal plants used in traditional medicine that are used to prevent and treat Covid-19 such as and . However, harvesting shrubs for fuel wood and overgrazing is threatening the flora biodiversity found in these range lands and the lives of the people who live there. This calls for urgent action.

Abbreviations

None.

Acknowledgments

The author would like to thank all the participants who entirely voluntarily participated in this study for providing their detailed and thoughtful responses.

Author’s contributions

None

Funding

None

Availability of data and materials

Data and materials used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

  1. N.H. ColeL. J. G. van der Maesen, X. M. van der Burgt, J. M. van Medenbach de Roy. Diversity of Medicinal Plants in West African Habitats.. 14th {AETFAT} {C}ongress 1996; : 704-713.
  2. P.G. Xiao. The Chinese approach to medicinal plants their utilization and conservation. 1991; : 305-13.
  3. . He SA, Sheng H. 1997. Utilization and conservation of medicinal plants in China with special reference to Atractylodes lancea. In: FAO. (1997). Medicinal Plants for Forest Conservation and Healthcare. FAO, Rome, Italy.. :
  4. J.M. Woo, S.H. Cho. Traditional Korean medicine practitioners' attitudes toward evidence based medicine: a qualitative study. Eur J Integr Med 2012; 4(4): e448-54.
  5. FAO. Use and potential of wild plants in farm households. 1999; :
  6. G. Gintzburger, K. Toderich, B. Mardonov, M. Mahmudov. Rangelands of the Arid and Semi-Arid zones in Uzbekistan. ClRAD-ICARDA.. 2003; :
  7. M.K. Hasan, P. Gatto, P.K. Jha. Can environmental income from wild medicinal plants contributes to annual household income: a case study from Makawanpur district in Nepal. International Journal of Medicinal and Aromatic. 2013; 3: 18-26.
  8. G. Rasul, D. Choudhary, B.H. Pandit, M. Kollmair. Poverty and livelihood impacts of a medicinal and aromatic plants project in India and Nepal: an assessment. Mt Res Dev 2012; 32(2): 137-48.
  9. H. Sher, A. Aldosari, A. Ali, H.J. de Boer. Economic benefits of high value medicinal plants to Pakistani communities: an analysis of current practice and potential. J Ethnobiol Ethnomed 2014; 10(1): 71.
  10. . IUCN. 2006. Conserving Medicinal Species. Securing a Healthy Future. Miththapala S. (ed) IUCN: Ecosystems and Livelihoods Group, Asia.. :
  11. M. Gamoun, A.O. Belgacem, M. Louhaichi. Diversity of desert rangelands of Tunisia. Plant Divers 2018; 40(5): 217-25.
  12. M. Gamoun, M. Louhaichi. Botanical Composition and Species Diversity of Arid and Desert Rangelands in Tataouine, Tunisia. Land (Basel) 2021; 10(3): 313.
  13. E. Le Floc'h. Contribution à une Étude Ethnobotanique de la Flore Tunisienne. 1983; :
  14. H. You, H. Jin, A. Khaldi, M. Kwak, T. Lee, I. Khaine. Plant Diversity in Different Bioclimatic Zones in Tunisia. J Asia-Pac Biodivers 2016; 9(1): 56-62.
  15. M. Neffati, H. Najjaa, A. Máthé. Medicinal and Aromatic Plants of the World—Africa; Springer Nature: Berin/Heidelberg, Germany, Volume 3.. 2017; :
  16. O. Karous, I. Ben Haj Jilani, Z. Ghrabi-Gammar. Ethnobotanical Study on Plant Used by Semi-Nomad Descendants' Community in Ouled Dabbeb-Southern Tunisia. Plants 2021; 10(4): 642.
  17. . World Health Organisation (2021). Timeline: WHO’s COVID-19 response. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2011/interactive-timeline (Accessed Jul 25, 2021).. 2021; :
  18. . Ministry of Public Health 2021. :
  19. M. Louhaichi, M. Gamoun. Rosmarinus officinalis: a multi-purpose species; a medicinal, aromatic, and ornamental plant. Managing rangelands: promoting pastoral species that are more popular and widely effective medicinal values. 2020; :
  20. G. Altinier, S. Sosa, R.P. Aquino, T. Mencherini, R. Della Loggia, A. Tubaro. Characterization of topical antiinflammatory compounds in Rosmarinus officinalis L. J Agric Food Chem 2007; 55(5): 1718-23.
  21. D. Poeckel, C. Greiner, M. Verhoff, O. Rau, L. Tausch, C. Hörnig. Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-inflammatory responses of stimulated human polymorphonuclear leukocytes. Biochem Pharmacol 2008; 76(1): 91-7.
  22. C.S. Lai, J.H. Lee, C.T. Ho, C.B. Liu, J.M. Wang, Y.J. Wang. Rosmanol potently inhibits lipopolysaccharide-induced iNOS and COX-2 expression through downregulating MAPK, NF-kappaB, STAT3 and C/EBP signaling pathways. J Agric Food Chem 2009; 57(22): 10990-8.
  23. J.P. Benincá, J.B. Dalmarco, M.G. Pizzolatti, T.S. Fröde. Analysis of the anti-inflammatory properties of Rosmarinus officinalis L. in mice. Food Chem 2011; 124(2): 468-75.
  24. M. Oluwatuyi, G.W. Kaatz, S. Gibbons. Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry 2004; 65(24): 3249-54.
  25. Z. Marzouk, A. Neffati, B. Marzouk, I. Charaief, K. Fathia, L. Chakir Ghedira. Chemical composition and antibacterial and antimutagenic activity of Tunisian Rosmarinus officinalis L. oil from Kasserine. J Food Agric Environ 2006; 4: 61-5.
  26. A.I. Hussain, F. Anwar, S.A. Chatha, A. Jabbar, S. Mahboob, P.S. Nigam. Rosmarinus officinalis essential oil: antiproliferative, antioxidant and antibacterial activities. Braz J Microbiol 2010; 41(4): 1070-8.
  27. J.J. Al Zuhairi, F.J. Kashi, A. Rahimi-Moghaddam, M. Yazdani. Antioxidant, cytotoxic and antibacterial activity of Rosmarinus officinalis L. essential oil against bacteria isolated from urinary tract infection. Eur J Integr Med 2020; 38: 101-92.
  28. M. Jardak, J. Elloumi-Mseddi, S. Aifa, S. Mnif. Chemical composition, anti-biofilm activity and potential cytotoxic effect on cancer cells of Rosmarinus officinalis L. essential oil from Tunisia. Lipids Health Dis 2017; 16(1): 190.
  29. O.O. Okoh, A.P. Sadimenko, A.J. Afolayan. Comparative evaluation of the antibacterial activities of the essential oils of Rosmarinus officinalis L. obtained by hydrodistillation and solvent free microwave extraction methods. Food Chem 2010; 120(1): 308-12.
  30. I. Takaki, L.E. Bersani-Amado, A. Vendruscolo, S.M. Sartoretto, S.P. Diniz, C.A. Bersani-Amado. Anti-inflammatory and antinociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models. J Med Food 2008; 11(4): 741-6.
  31. A.L. Martínez, M.E. González-Trujano, M. Chávez, F. Pellicer. Antinociceptive effectiveness of triterpenes from rosemary in visceral nociception. J Ethnopharmacol 2012; 142(1): 28-34.
  32. R. Lucarini, W.A. Bernardes, D.S. Ferreira, M.G. Tozatti, R. Furtado, J.K. Bastos. In vivo analgesic and anti-inflammatory activities of Rosmarinus officinalis aqueous extracts, rosmarinic acid and its acetyl ester derivative. Pharm Biol 2013; 51(9): 1087-90.
  33. R. Sedighi, Y. Zhao, A. Yerke, S. Sang. Preventive and protective properties of rosemary (Rosmarinus officinalis L.) in obesity and diabetes mellitus of metabolic disorders: a brief review. Curr Opin Food Sci 2015; 2: 58-70.
  34. A. Rašković, I. Milanović, N. Pavlović, T. Ćebović, S. Vukmirović, M. Mikov. Antioxidant activity of rosemary (Rosmarinus officinalis L.) essential oil and its hepatoprotective potential. BMC Complement Altern Med 2014; 14(14): 225.
  35. K.S. Ramadan, O.A. Khalil, E.N. Danial, H.S. Alnahdi, N.O. Ayaz. Hypoglycemic and hepatoprotective activity of Rosmarinus officinalis extract in diabetic rats. J Physiol Biochem 2013; 69(4): 779-83.
  36. C.L. Hsieh, C.H. Peng, C.C. Chyau, Y.C. Lin, H.E. Wang, R.Y. Peng. Low-density lipoprotein, collagen, and thrombin models reveal that Rosemarinus officinalis L. exhibits potent antiglycative effects. J Agric Food Chem 2007; 55(8): 2884-91.
  37. G. Beretta, R. Artali, R.M. Facino, F. Gelmini. An analytical and theoretical approach for the profiling of the antioxidant activity of essential oils: the case of Rosmarinus officinalis L. J Pharm Biomed Anal 2011; 55(5): 1255-64.
  38. N. Hendel, L. Larous, L. Belbey. Antioxidant activity of rosemary (Rosmarinus offcinalis L.) and its in vitro inhibitory effect on Penicillium digitatum. Int Food Res J 2016; 23: 1725-32.
  39. C. Takayama, F.M. Faria, A.C. Almeida, R.J. Dunder, L.P. Manzo, E.A. Socca. Chemical composition of Rosmarinus officinalis essential oil and antioxidant action against gastric damage induced by absolute ethanol in the rat. Asian Pac J Trop Biomed 2016; 6(8): 677-81.
  40. S.C. Degner, A.J. Papoutsis, D.F. RomagnoloR. Ross Watson. Health benefits of traditional culinary and medicinal Mediterranean plants. 2009; : 541-62.
  41. S. Gezici, N. Sekeroglu, A. Kijjoa. In vitro anticancer activity and antioxidant properties of essential oils from populus alba L. and Rosmarinus officinalis L. from South Eastern Anatolia of Turkey. Indian Journal of Pharmaceutical Education and Research 2017; 51: 498-503.
  42. N. Jarrar, A. Abu-Hijleh, K. Adwan. Antibacterial activity of Rosmarinus officinalis L. alone and in combination with cefuroxime against methicillin-resistant Staphylococcus aureus. Asian Pac J Trop Med 2010; 3(2): 121-3.
  43. W.A. Bernardes, R. Lucarini, M.G. Tozatti, L.G. Flauzino, M.G. Souza, I.C. Turatti. Antibacterial activity of the essential oil from Rosmarinus officinalis and its major components against oral pathogens. Z Naturforsch C J Biosci 2010; 65(9-10): 588-93.
  44. B. Bozin, N. Mimica-Dukic, I. Samojlik, E. Jovin. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J Agric Food Chem 2007; 55(19): 7879-85.
  45. M.M. Özcan, J.C. Chalchat. Chemical composition and antifungal activity of rosemary (Rosmarinus officinalis L.) oil from Turkey. Int J Food Sci Nutr 2008; 59(7-8): 691-8.
  46. I. Rasooli, M.H. Fakoor, D. Yadegarinia, L. Gachkar, A. Allameh, M.B. Rezaei. Antimycotoxigenic characteristics of Rosmarinus officinalis and Trachyspermum copticum L. essential oils. Int J Food Microbiol 2008; 122(1-2): 135-9.
  47. O. Bouraoui. La médecine traditionnelle dans le gouvernorat de Sousse. Thèse de Médecine. Faculté de médecine de Sousse, Tunisie.. 2000; :
  48. E. Stahl-Biskup, F. Sáez. Thyme, the Genus Thymus. 2002; :
  49. I. Ben El Hadj Ali, A. Guetat, M. Boussaid. A combined approach using allozymes and volatiles for the characterization of Tunisian Thymbra capitata (L.) Cav. (Lamiaceae). Ind Crops Prod 2013; 43: 477-83.
  50. A. Neves, J. Marto, A. Duarte, L.M. Gonçalves, P. Pinto, A.C. Figueiredo, H.M. Ribeiro. Characterization of Portuguese Thymbra capitata, Thymus caespititius and Myrtus communis essential oils in topical formulations. Flavour Frag. J. 32 : 392–402. . :
  51. S. Aazza, S. El-Guendouz, M.G. Miguel, M.D. Antunes, M.L. Faleiro, A.I. Correia. Antioxidant, Anti-inflammatory and Anti-hyperglycaemic Activities of Essential Oils from Thymbra capitata, Thymus albicans, Thymus caespititius, Thymus carnosus, Thymus lotocephalus and Thymus mastichina from Portugal. Nat Prod Commun 2016; 11(7): 1029-38.
  52. A. Carrasco, E. Perez, A.B. Cutillas, R. Martinez-Gutierrez, V. Tomas, J. Tudela. Origanum vulgare and Thymbra capitata Essential Oils from Spain: Determination of Aromatic Profile and Bioactivities. Nat Prod Commun 2016; 11(1): 113-20.
  53. S.M. Albano, M.G. Miguel. Biological activities of extracts of plants grown in Portugal. Ind Crops Prod 2011; 33(2): 338-43.
  54. A. Palmeira-de-Oliveira, R. Palmeira-de-Oliveira, A. Gaspar, L. Salgueiro, C. Cavaleiro, J. Martinez-de-Oliveira. Association of Thymbra capitata essential oil and chitosan (TCCH hydrogel): a putative therapeutic tool for the treatment of vulvovaginal candidosis. Flavour Fragrance J 2013; 28(6): 354-9.
  55. L. Faleiro, G. Miguel, S. Gomes, L. Costa, F. Venâncio, A. Teixeira. Antibacterial and antioxidant activities of essential oils isolated from Thymbra capitata L. (Cav.) andOriganum vulgare L. J Agric Food Chem 2005; 53(21): 8162-8.
  56. N. Merino, D. Berdejo, R. Bento, H. Salman, M. Lanz, F. Maggi. Antimicrobial efficacy of Thymbra capitata (L.) Cav. essential oil loaded in self-assembled zein nanoparticles in combination with heat. Ind Crops Prod 2019; 133: 98-104.
  57. A.M. D\vzamić, B.J. Nikolić, A.A. Giweli, D.S. Mitić-Ćulafić, M.D. Soković, M.S. Ristić. Libyan Thymus capitatus essential oil: antioxidant, antimicrobial, cytotoxic and colon pathogen adhesion-inhibition properties. J Appl Microbiol 2015; 119(2): 389-99.
  58. A. Elmi, D. Ventrella, F. Barone, S. Benvenuti, M. Scozzoli, M.L. Bacci. Preliminary evaluations of the effects of Cuminum cyminum and Coriandrum sativum essential oils on swine spermatozoa. JSM Sex. Med. 2017; 2: 1012.
  59. G. Sacchetti, S. Maietti, M. Muzzoli, M. Scaglianti, S. Manfredini, M. Radice. Comparative evaluation of 11 essential oils of different origin as functional antioxidants, antibacterials and antimicrobials in foods. Food Chem 2005; 91(4): 621-32.
  60. S. Bounatirou, S. Smiti, M.G. Miguel, L. Faleiro, M.N. Rejeb, M. Neffati. Chemical composition, antioxidant and antibacterial activities of the essential oils isolated from Tunisian Thymus capitatus Hoff. et Link. Food Chem 2007; 105(1): 146-55.
  61. J. Delgado-Adámez, M. Garrido, M.E. Bote, M.C. Fuentes-Pérez, J. Espino, D. Martín-Vertedor. Chemical composition and bioactivity of essential oils from flower and fruit of Thymbra capitata and Thymus species. J Food Sci Technol 2017; 54(7): 1857-65.
  62. M.G. Miguel, C. Gago, M.D. Antunes, C. Megías, I. Cortés-Giraldo, J. Vioque. Antioxidant and antiproliferative activities of the essential oils from Thymbra capitata and Thymus species grown in Portugal. Evid Based Complement Alternat Med 2015; 2015: 851721.
  63. L.R. Salgueiro, E. Pinto, M.J. Gonçalves, C. Pina-Vaz, C. Cavaleiro, A.G. Rodrigues. Chemical composition and antifungal activity of the essential oil of Thymbra capitata. Planta Med 2004; 70(6): 572-5.
  64. I.B. Ali, A. Guetat, M. Boussaid. Variation of volatiles in Tunisian populations of Thymbra capitata (L.) Cav. (Lamiaceae). Chem Biodivers 2012; 9(7): 1272-85.
  65. R. Jaouadi, S.M. Cardoso, A.M. Silva, I. Ben Hadj Yahia, M. Boussaid, Y. Zaouali. Variation of phenolic constituents of Tunisian Thymus capitatus (L.) Hoff. et Link. populations. Biochem Syst Ecol 2018; 77: 10-5.
  66. A. Moukhles, H. Belcadi, I. Raissouni, A. Ben Driss, A. Ibn Mansour. Chemical Composition, in vitro Antibacterial Activity and Corrosion Inhibition of Essential Oil and Hydrolat Extract from Aerial Parts of Thymbra capitata (L.) Cav Harvested at Northern Morocco. Journal of Essential Oil Bearing Plants 2020; 23(2): 375-389.
  67. M. Gamoun, M. Louhaichi. Peganum harmala L.: noxious invasive species, toxic to livestock but medicinally important. Managing agrosilvopastoral systems: controlling invasive perennial species. 2021; :
  68. M.A. Kuhn, D. Winston. Herbal therapy and supplements, a scientific and traditional approach. 2000; : 350-74.
  69. A. Yuruktumen, S. Karaduman, F. Bengi, J. Fowler. Syrian rue tea: a recipe for disaster. Clin Toxicol (Phila) 2008; 46(8): 749-52.
  70. M. El-Saad El-Rifaie, M. Rifaie. Peganum harmala: its use in certain dermatoses. Int J Dermatol 1980; 19(4): 221-2.
  71. C.N. Mina, M.H. Farzaei, A. Gholamreza. Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: a review. J Tradit Chin Med 2015; 35(1): 104-9.
  72. N. Goel, N. Singh, R. Saini. Efficient in vitro multiplication of Syrian Rue (Peganum harmala L.) using 6-benzylaminopurine pre-conditioned seedling explants. Nat Sci 2009; 7: 129-34.
  73. M. Mirzaie, S.J. Nosratabadi, A. Amin Derakhshanfar, I. Sharifi. Antileishmanial activity of Peganum harmala extract on the in vitro growth of Leishmania major promastigotes in comparison to a trivalent antimony drug. Vet Arh 2007; 77(4): 365-75.
  74. G. Asghari, G.B. Lockwood. Stereo specific biotransformation of phenylethyl propionate by cell cultures of Peganum harmala L. Iran Biomed J 2002; 6: 43-6.
  75. F. Zaker, A. Oody, A. Arjmand. A study on the antitumoral and differentiation effects of peganum harmala derivatives in combination with ATRA on leukaemic cells. Arch Pharm Res 2007; 30(7): 844-9.
  76. H.R. Monsef, A. Ghobadi, M. Iranshahi, M. Abdollahi. Antinociceptive effects of Peganum harmala L. alkaloid extract on mouse formalin test. J Pharm Pharm Sci 2004; 7(1): 65-9.
  77. K. Hamden, H. Masmoudi, F. Ellouz, A. ElFeki, S. Carreau. Protective effects of Peganum harmala extracts on thiourea-induced diseases in adult male rat. J Environ Biol 2008; 29(1): 73-7.
  78. A.M. Sobhani, S.A. Ebrahimi, M. Mahmoudian. An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids. J Pharm Pharm Sci 2002; 5(1): 19-23.
  79. E. Darabpour, A. Poshtkouhian Bavi, H. Motamedi, S.M. Seyyed Nejad. Antibacterial activity of different parts of Peganum harmala L. growing in Iran against multi-drug resistant bacteria. EXCLI J 2011; 10: 252-63.
  80. M.K. Boukef. Les plantes dans la médecine traditionnelle en Tunisie. In: Médecine traditionnelle et pharmacopée. Edits., Agence de Coopération culturelle et Technique, pp. 95–96, Paris, France.. :
  81. A. Tahraoui, J. El-Hilaly, Z.H. Israili, B. Lyoussi. Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province). J Ethnopharmacol 2007; 110(1): 105-17.
  82. S. Salido, L.R. Valenzuela, J. Altarejos, M. Nogueras, A. Sanchez, E. Cano. Composition and infraspecific variability of Artemisia herba-alba from southern Spain. Biochem Syst Ecol 2004; 32(3): 265-77.
  83. A.E. Mohamed, M.A. El-Sayed, M.E. Hegazy, S.E. Helaly, A.M. Esmail, N.S. Mohamed. Chemical Constituents and Biological Activities of Artemisia Herba Alba. Rec Nat Prod 2010; 4: 1-25.
  84. D. Khlifi, R.M. Sghaier, S. Amouri, D. Laouini, M. Hamdi, J. Bouajila. Composition and anti-oxidant, anti-cancer and anti-inflammatory activities of Artemisia herba-alba, Ruta chalpensis L. and Peganum harmala L. Food Chem Toxicol 2013; 55: 202-8.
  85. H. Mighri, H. Hajlaoui, A. Akrout, N. Najjaa, M. Neffati. Antimicrobial and antioxidant activities of Artemisia herba-alba essential oil cultivated in Tunisian arid zone. C R Chim 2010; 13(3): 380-6.
  86. S.M. Abderrahman, S.J. Shbailat. Genotoxic and cytotoxic effects of Artemisia herba-alba on mammalian cells. Caryologia: International Journal of Cytology. Cytosystematics and Cytogenetics. 2014; 67: 265-72.
  87. M.A. Saleh, M.H. Belal, G. el-Baroty. Fungicidal activity of Artemisia herba alba Asso (Asteraceae). J Environ Sci Health B 2006; 41(3): 237-44.
  88. F. Younsi, R. Trimech, A. Boulila, O. Ezzine, S. Dhahri, M. Boussaid. Essential Oil and Phenolic Compounds of Artemisia herba-alba (Asso.): Composition, Antioxidant, Antiacetylcholinesterase, and Antibacterial Activities. Int J Food Prop 2016; 19(7): 1425-38.
  89. S. Chermat, R. Gharzouli. Ethnobotanical study of medicinal flora in the North East of Algeria-An empirical knowledge in Djebel Zdimm (Setif). J Mar Sci Eng 2015; 5: 50-9.
  90. A. Labed, M. Ferhat, I. Labed-Zouad, E. Kaplaner, S. Zerizer, L. Voutquenne-Nazabadioko. Compounds from the pods of Astragalus armatus with antioxidant, anticholinesterase, antibacterial and phagocytic activities. Pharm Biol 2016; 54(12): 3026-32.
  91. Z. Boual, G. Pierre, C. Delattre, F. Benaoun, E. Petit, C. Gardarin. Mediterranean semi-arid plant Astragalus armatus as a source of bioactive galactomannan. Bioact. Carbohydr. Diet. Fibre. 2015; 5(1): 10-8.
  92. H.W. Zhang, Z.X. Lin, C. Xu, C. Leung, L.S. Chan. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease. Cochrane Database Syst Rev 2014; 10(10):
  93. B.M. Shao, W. Xu, H. Dai, P. Tu, Z. Li, X.M. Gao. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun 2004; 320(4): 1103-11.
  94. W.A. Wannes, M.S. Tounsi. Can medicinal plants contribute to the cure of Tunisian COVID-19 patients?. Journal of Medicinal Plants Studies 2020; 8(5): 218-26.
  95. A. El Alami, A. Fattah, A. Chait. Medicinal Plants Used for the Prevention Purposes during the Covid-19 Pandemic in Morocco. J. Anal. Sci. Appl. Biotech. 2020; 2(1): 4-11.
  96. O. Sytar, M. Brestic, S. Hajihashemi, M. Skalicky, J. Kubeš, L. Lamilla-Tamayo. COVID-19 Prophylaxis Efforts Based on Natural Antiviral Plant Extracts and Their Compounds. Molecules 2021; 26(3): 727.
  97. E.F. Silva, P.F. Silva, T.M. Rico. Anti-Sars-CoV effect of Rosemary (Rosmarinus officinalis): A blind docking strategy. MOL2NET, International Conference Series on Multidisciplinary Sciences CHEMINFOUNC-02: Chemoinformatics Workshop, UNC Chape Hill, USA. :
  98. C. Lionis, I. Karakasiliotis, E. Petelos, M. Linardakis, A. Diamantakis, E. Symvoulakis. A mixture of essential oils from three Cretan Aromatic Plants (thyme, Greek sage and Cretan dittany, CAPeo) inhibits SASR-CoV-2 proliferation: in vitro evidence and a Proof-of-Concept intervention study in mild ambulatory COVID-19-positive patients. medRxiv.; 2021.01.11.20248947.. :
  99. B. Tuzun, T. Nasibova, E. Garaev, K. Sayin, H. Ataseven. Could Peganum harmala be effective in the treatment of COVID-19?. Bratisl Lek Listy 2021; 122(9): 670-9.
  100. M.T. Moradi, A. Karimi, M. Rafieian-Kopaei, F. Fotouhi. In vitro antiviral effects of Peganum harmala seed extract and its total alkaloids against Influenza virus. Microb Pathog 2017; 110: 42-9.
  101. A. Asdadi, A. Hamdouch, S. Gharby, L.A. Idrissi Hassani. Chemical characterization of essential oil of Artemisia herba-alba asso and his possible potential against covid-19. J. Analyt Sci Appl Biotechnology 2020; 2(2): 67-72.
  102. A.F. Attah, A.A. Fagbemi, O. Olubiyi. Therapeutic potentials of ant-iviral plants used in traditional African medicine with COVID-19 infocus: a Nigerian perspective. Front Pharmacol 2021; 12: 1-29.
  103. H. Luo, Q.L. Tang, Y.X. Shang, S.B. Liang, M. Yang, N. Robinson. Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs . Chin J Integr Med 2020; 26(4): 243-250.

Comments